{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:55:35Z","timestamp":1762102535241},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12012-020-09596-0","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T10:04:01Z","timestamp":1596017041000},"page":"443-447","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["COVID-19: A Concern for Cardiovascular Disease Patients"],"prefix":"10.1007","volume":"20","author":[{"given":"Shruti","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"9596_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046941","author":"KJ Clerkin","year":"2020","unstructured":"Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., et al. (2020). Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.046941.","journal-title":"Circulation"},{"key":"9596_CR2","unstructured":"Novel Coronavirus (2019-nCoV) situation reports-181; World Health Organization. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200719-covid-19-sitrep-181.pdf?sfvrsn=82352496_2."},{"key":"9596_CR3","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., et al. (2017). Heart disease and stroke statistics\u20142017 update: A report from the American Heart Association. Circulation, 135, e146\u2013e603. https:\/\/doi.org\/10.1161\/CIR.0000000000000485.","journal-title":"Circulation"},{"key":"9596_CR4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","author":"W Guan","year":"2020","unstructured":"Guan, W., Ni, Z., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., et al. (2020). Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. https:\/\/doi.org\/10.1056\/NEJMoa2002032.","journal-title":"The New England Journal of Medicine"},{"key":"9596_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2020.03.003003","author":"Y Qiu","year":"2020","unstructured":"Qiu, Y., Zhao, Y. B., Wang, Q., Li, J. Y., Zhou, Z. J., Liao, C. H., et al. (2020). Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2. Clinical Microbiology and Infection. https:\/\/doi.org\/10.1016\/j.micinf.2020.03.003003.","journal-title":"Clinical Microbiology and Infection"},{"key":"9596_CR6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","volume":"9","author":"J Meng","year":"2020","unstructured":"Meng, J., Xiao, G., Zhang, J., He, X., Ou, M., Bi, J., et al. (2020). Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerging Microbes & Infections, 9, 757\u2013760. https:\/\/doi.org\/10.1080\/22221751.2020.1746200.","journal-title":"Emerging Microbes & Infections"},{"key":"9596_CR7","first-page":"85","volume":"133","author":"H Talreja","year":"2020","unstructured":"Talreja, H., Tan, J., Dawes, M., Supershad, S., Rabindranath, K., Fisher, J., et al. (2020). A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019). New Zealand Medical Journal, 133, 85\u201387.","journal-title":"New Zealand Medical Journal"},{"key":"9596_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4812","author":"AB Patel","year":"2020","unstructured":"Patel, A. B., & Verma, A. (2020). COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: What is the evidence? JAMA. https:\/\/doi.org\/10.1001\/jama.2020.4812.","journal-title":"JAMA"},{"key":"9596_CR9","doi-asserted-by":"publisher","first-page":"e016509","DOI":"10.1161\/JAHA.120.016509","volume":"9","author":"R Sommerstein","year":"2020","unstructured":"Sommerstein, R., Kochen, M. M., Messerli, F. H., & Gr\u00e4ni, C. (2020). Coronavirus disease 2019 (COVID-19): Do angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers have a biphasic effect? Journal of the American Heart Association, 9, e016509. https:\/\/doi.org\/10.1161\/JAHA.120.016509.","journal-title":"Journal of the American Heart Association"},{"key":"9596_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jmii.2020.04.015","volume":"53","author":"CA Devaux","year":"2020","unstructured":"Devaux, C. A., Rolain, J. M., & Raoult, D. (2020). ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. Journal of Microbiology, Immunology, and Infection, 53, 425\u2013435. https:\/\/doi.org\/10.1016\/j.jmii.2020.04.015.","journal-title":"Journal of Microbiology, Immunology, and Infection"},{"key":"9596_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London England), 395, 497\u2013506. https:\/\/doi.org\/10.1016\/s0140-6736(20)30183-5.","journal-title":"Lancet (London England)"},{"key":"9596_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1465-9921-6-8","volume":"6","author":"DA Groneberg","year":"2005","unstructured":"Groneberg, D. A., Hilgenfeld, R., & Zabel, P. (2005). Molecular mechanisms of severe acute respiratory syndrome (SARS). Respiratory Research, 6, 8. https:\/\/doi.org\/10.1186\/1465-9921-6-8.","journal-title":"Respiratory Research"},{"key":"9596_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017Feb20","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., et al. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382, 727\u2013733. https:\/\/doi.org\/10.1056\/NEJMoa2001017Feb20.","journal-title":"The New England Journal of Medicine"},{"key":"9596_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0695-z","author":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses","year":"2020","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. (2020). The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology. https:\/\/doi.org\/10.1038\/s41564-020-0695-z.","journal-title":"Nature Microbiology"},{"key":"9596_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","volume":"49","author":"A Badawi","year":"2016","unstructured":"Badawi, A., & Ryoo, S. G. (2016). Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis. International Journal of Infectious Diseases, 49, 129\u2013133. https:\/\/doi.org\/10.1016\/j.ijid.2016.06.015.","journal-title":"International Journal of Infectious Diseases"},{"key":"9596_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0820-9","author":"KG Andersen","year":"2020","unstructured":"Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020). The proximal origin of SARS-CoV-2. Nature Medicine. https:\/\/doi.org\/10.1038\/s41591-020-0820-9.","journal-title":"Nature Medicine"},{"key":"9596_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2020.03.022","author":"TWQ Zhang","year":"2020","unstructured":"Zhang, T. W. Q., & Zhang, Z. (2020). Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Current Biology. https:\/\/doi.org\/10.1016\/j.cub.2020.03.022.","journal-title":"Current Biology"},{"key":"9596_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2179-y","author":"J Shang","year":"2020","unstructured":"Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., et al. (2020). Structural basis of receptor recognition by SARS-CoV-2. Nature. https:\/\/doi.org\/10.1038\/s41586-020-2179-y.","journal-title":"Nature"},{"key":"9596_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M., Kleine-Weber, H., Schroeder, S., Kr\u00fcger, N., Herrler, T., Erichsen, S., et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052.","journal-title":"Cell"},{"key":"9596_CR20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032Feb28","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J., Ni, Z. Y., Hu, Y., et al. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. https:\/\/doi.org\/10.1056\/NEJMoa2002032Feb28.","journal-title":"New England Journal of Medicine"},{"key":"9596_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(20)30074-7","author":"J Hellewell","year":"2020","unstructured":"Hellewell, J., Abbott, S., Gimma, A., Bosse, N. I., Jarvis, C. I., Russell, T. W., et al. (2020). Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Global Health. https:\/\/doi.org\/10.1016\/s2214-109x(20)30074-7.","journal-title":"Lancet Global Health"},{"key":"9596_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2565","author":"Y Bai","year":"2020","unstructured":"Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D. Y., Chen, L., et al. (2020). Presumed asymptomatic carrier transmission of COVID19. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.2565.","journal-title":"JAMA"},{"key":"9596_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(20)30113-4","author":"Y Pan","year":"2020","unstructured":"Pan, Y., Zhang, D., Yang, P., Poon, L. L. M., & Wang, Q. (2020). Viral load of SARS-CoV-2 in clinical samples. Lancet Infectious Diseases. https:\/\/doi.org\/10.1016\/s1473-3099(20)30113-4.","journal-title":"Lancet Infectious Diseases"},{"key":"9596_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30360-3","author":"H Chen","year":"2020","unstructured":"Chen, H., Guo, J., Wang, C., Luo, F., Yu, X., Zhanget, W., et al. (2020). Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. Lancet. https:\/\/doi.org\/10.1016\/s0140-6736(20)30360-3.","journal-title":"Lancet"},{"key":"9596_CR25","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/22221751.2020.1729071","volume":"9","author":"W Zhang","year":"2020","unstructured":"Zhang, W., Du, R. H., Li, B., et al. (2020). Molecular and serological investigation of 2019- nCoV infected patients: Implication of multiple shedding routes. Emerging Microbes & Infections, 9, 386\u2013389. https:\/\/doi.org\/10.1080\/22221751.2020.1729071.","journal-title":"Emerging Microbes & Infections"},{"key":"9596_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann, M., Verleden, S. E., Kuehnel, M., et al. (2020). Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. New England Journal of Medicine, 383, 120\u2013128. https:\/\/doi.org\/10.1056\/NEJMoa2015432.","journal-title":"New England Journal of Medicine"},{"key":"9596_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa106","author":"TJ Guzik","year":"2020","unstructured":"Guzik, T. J., Mohiddin, S. A., Dimarco, A., Patel, V., Savvatis, K., Marelli-Berget, F. M., et al. (2020). COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research. https:\/\/doi.org\/10.1093\/cvr\/cvaa106.","journal-title":"Cardiovascular Research"},{"key":"9596_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, 395, 507\u2013513. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7.","journal-title":"Lancet"},{"key":"9596_CR29","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.0934","author":"C Yang","year":"2020","unstructured":"Yang, C., & Jin, Z. (2020). An acute respiratory infection runs into the most common noncommunicable epidemic-COVID-19 and cardiovascular diseases. JAMA Cardiology. https:\/\/doi.org\/10.1001\/jamacardio.2020.0934.","journal-title":"JAMA Cardiology"},{"key":"9596_CR30","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1286","author":"M Madjid","year":"2020","unstructured":"Madjid, M., Safavi-Naeini, P., Solomon, S. D., & Vardeny, O. (2020). Potential effects of coronaviruses on the cardiovascular system: A review. JAMA Cardiology. https:\/\/doi.org\/10.1001\/jamacardio.2020.1286.","journal-title":"JAMA Cardiology"},{"key":"9596_CR31","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet, 395, 1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","journal-title":"Lancet"},{"key":"9596_CR32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585","author":"D Wang","year":"2020","unstructured":"Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., et al. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus infected pneumonia in Wuhan, China. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.1585.","journal-title":"JAMA"},{"key":"9596_CR33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J., Ni, Z. Y., Hu, Y., Hu, Y., Liang, W. H., Ou, C. Q., et al. (2020). China medical treatment expert group for covid-19. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. https:\/\/doi.org\/10.1056\/NEJMoa2002032.","journal-title":"The New England Journal of Medicine"},{"key":"9596_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C. L., Abiona, O., et al. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. https:\/\/doi.org\/10.1126\/science.abb2507.","journal-title":"Science"},{"key":"9596_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/pgmj.2005.037515","volume":"82","author":"CM Yu","year":"2006","unstructured":"Yu, C. M., Wong, R. S., Wu, E. B., Kong, S. L., Wong, J., Yip, G. W., et al. (2006). Cardiovascular complications of severe acute respiratory syndrome. Postgraduate Medical Journal, 82, 140\u2013144. https:\/\/doi.org\/10.1136\/pgmj.2005.037515.","journal-title":"Postgraduate Medical Journal"},{"key":"9596_CR36","doi-asserted-by":"publisher","first-page":"S2213","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"20","author":"Z Xu","year":"2020","unstructured":"Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., et al. (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine, 20, S2213\u20132600. https:\/\/doi.org\/10.1016\/S2213-2600(20)30076-X.","journal-title":"The Lancet Respiratory Medicine"},{"key":"9596_CR37","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1161\/01.CIR.0000094737.21775.32","volume":"108","author":"SS Li","year":"2003","unstructured":"Li, S. S., Cheng, C. W., Fu, C. L., Chan, Y. H., Lee, M. P., Chan, J. W., et al. (2003). Left ventricular performance in patients with severe acute respiratory syndrome. Circulation, 108, 1798\u20131803. https:\/\/doi.org\/10.1161\/01.CIR.0000094737.21775.32.","journal-title":"Circulation"},{"key":"9596_CR38","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","volume":"116","author":"L Chen","year":"2020","unstructured":"Chen, L., Li, X., Chen, M., Feng, Y., & Xiong, C. (2020). The ACE2 expression in human heart indicates new potential mechanism of heart injury amongng patients infected with SARS-CoV-2. Cardiovascular Research, 116, 1097\u20131100. https:\/\/doi.org\/10.1093\/cvr\/cvaa078.","journal-title":"Cardiovascular Research"},{"key":"9596_CR39","doi-asserted-by":"publisher","first-page":"256294","DOI":"10.1155\/2012\/256294","volume":"2012","author":"C Tikellis","year":"2012","unstructured":"Tikellis, C., & Thomas, M. C. (2012). Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. International Journal of Peptide Research, 2012, 256294. https:\/\/doi.org\/10.1155\/2012\/256294.","journal-title":"International Journal of Peptide Research"},{"key":"9596_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05985-9","author":"H Zhang","year":"2020","unstructured":"Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Medicine. https:\/\/doi.org\/10.1007\/s00134-020-05985-9.","journal-title":"Intensive Care Medicine"},{"key":"9596_CR41","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"Ferrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., et al. (2005). Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation, 111, 2605\u20132610.","journal-title":"Circulation"},{"key":"9596_CR42","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","volume":"118","author":"VB Patel","year":"2016","unstructured":"Patel, V. B., Zhong, J. C., Grant, M. B., & Oudit, G. Y. (2016). Role of the ACE2\/angiotensin 1\u20137 axis of the renin-angiotensin system in heart failure. Circulation Research, 118, 1313\u20131326. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.307708.","journal-title":"Circulation Research"},{"key":"9596_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.biochi.2020.04.008","volume":"174","author":"M Alifano","year":"2020","unstructured":"Alifano, M., Alifano, P., Forgez, P., & Iannelli, A. (2020). Renin-angiotensin system at the heart of COVID-19 pandemic. Biochimie, 174, 30\u201333. https:\/\/doi.org\/10.1016\/j.biochi.2020.04.008.","journal-title":"Biochimie"},{"key":"9596_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41421-020-0147-1","volume":"6","author":"Y Cao","year":"2020","unstructured":"Cao, Y., Li, L., Feng, Z., Wan, S., Huang, P., Sun, X., et al. (2020). Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations. Cell Discovery, 6, 11. https:\/\/doi.org\/10.1038\/s41421-020-0147-1.","journal-title":"Cell Discovery"},{"key":"9596_CR45","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang, L., Karakiulakis, G., & Roth, M. (2020). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respiratory Medicine, 8, e21. https:\/\/doi.org\/10.1016\/S2213-2600(20)30116-8.","journal-title":"Lancet Respiratory Medicine"},{"key":"9596_CR46","doi-asserted-by":"publisher","first-page":"e016219","DOI":"10.1161\/JAHA.120.016219","volume":"9","author":"J Guo","year":"2020","unstructured":"Guo, J., Huang, Z., Lin, L., & Lv, J. (2020). Coronavirus disease 2019 (COVID-19) and cardiovascular disease: A viewpoint on the potential influence of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. Journal of the American Heart Association, 9, e016219. https:\/\/doi.org\/10.1161\/JAHA.120.016219.","journal-title":"Journal of the American Heart Association"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-020-09596-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-020-09596-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-020-09596-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T23:40:58Z","timestamp":1627515658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-020-09596-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["9596"],"URL":"https:\/\/doi.org\/10.1007\/s12012-020-09596-0","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"10 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by the author. Therefore, informed consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}